Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asset Protection Company (APC) is a specialized technology and service provider focused on real-time monitoring and laboratory safety for the life sciences, biotech, and healthcare industries. Operating primarily as XiltriX North America, the company provides a comprehensive "Monitoring-as-a-Service" (MaaS) platform that tracks critical environmental parameters such as temperature, humidity, CO2 levels, and equipment performance. Their flagship XiltriX system is designed to protect high-value biological assets, including sensitive research samples, pharmaceutical products, and embryos in IVF clinics. APC distinguishes itself by offering 24/7 remote monitoring by live experts who vet alarms to prevent "alarm fatigue" and ensure rapid response to critical failures. The company's solutions help laboratories maintain strict compliance with regulatory standards such as GxP, CAP/CLIA, and Joint Commission requirements. By integrating hardware, software, and professional services, APC provides a robust safety net for organizations where asset loss would be catastrophic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asset Protection Company.